Bourg-la-Reine, France

Helene Chopinet

This inventor holds 1 USPTO granted patent. Top assignee: Siemens Aktiengesellschaft. Active years: 2015.


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2015

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Helene Chopinet: Innovator in PET Imaging Technology

Introduction

Helene Chopinet is a notable inventor based in Bourg-la-Reine, France. She has made significant contributions to the field of medical imaging, particularly in the area of positron emission tomography (PET). Her innovative work has the potential to enhance the accuracy and effectiveness of PET imaging techniques.

Latest Patents

Helene Chopinet holds a patent for a method titled "Method for creating attenuation correction maps for PET image reconstruction." This method generates attenuation correction maps for the reconstruction of PET data using magnetic resonance (MR) images. It utilizes various MR imaging techniques, including ultra-fast TE (UTE) images and Dixon MR images, to improve the quality of PET imaging.

Career Highlights

Helene is currently employed at Siemens Aktiengesellschaft, a leading global technology company. Her work at Siemens focuses on advancing medical imaging technologies, contributing to the development of innovative solutions that enhance patient care.

Collaborations

Throughout her career, Helene has collaborated with esteemed colleagues, including Francisco Pereira and James G Reisman. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise in the field of medical imaging.

Conclusion

Helene Chopinet's contributions to PET imaging technology exemplify her dedication to innovation in the medical field. Her patented method for creating attenuation correction maps represents a significant advancement in imaging techniques, showcasing her impact on healthcare technology.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…